3653 results for «439»

Filter By

3653 results

Early outcomes and predictors of success in LATAM TAVI experiences

12 Sep 2025 – From PCR Rio Valves 2025

Explore early outcomes and predictors of success from Latin America's evolving experience with Transcatheter Aortic Valve Implantation (TAVI). This session covers innovative approaches such as transfemoral access intravascular lithotripsy compared to angioplasty, conduction disturbances with self-expandable TAVI devices, and insights from regional centers treating severe aortic...

PCR Gulf Valves 2025 Closing Ceremony

30 Sep 2025 – From PCR Gulf Valves 2025

Join the PCR Gulf Valves 2025 Closing Ceremony to reflect on the advancements and highlights of this year’s sessions dedicated to valvular interventions. This event marks the culmination of comprehensive educational activities, fostering collaboration and innovation in valvular heart disease management within the Gulf region.

PCR Gulf Valves 2025 Closing Ceremony

PCR Gulf Valves 2025 Opening Ceremony

29 Sep 2025 – From PCR Gulf Valves 2025

Join us for the PCR Gulf Valves 2025 Opening Ceremony, marking the commencement of an exceptional congress dedicated to advances in structural heart interventions. This session sets the stage for the latest innovations and expert discussions that will shape the future of valve therapies in the...

PCR Gulf Valves 2025 Opening Ceremony

Unusual presentations and diagnostic dilemmas

10 Oct 2025 – From AICT-AsiaPCR 2025

This session addresses unusual clinical presentations and diagnostic challenges encountered in cardiology practice. It features diverse cases including trauma-induced adrenal injury, acute chest pain in young patients, complex bifurcation stenting techniques, and intramural hematoma management, highlighting the importance of comprehensive evaluation and tailored interventional strategies.

Innovative imaging and guidance techniques

10 Oct 2025 – From AICT-AsiaPCR 2025

This session delves into innovative imaging and guidance techniques essential for managing complex coronary interventions. It encompasses challenging scenarios such as spontaneous coronary artery dissection, imaging-guided PCI fine-tuning complications, ruptured sinuses, and complex PCI in elderly patients with severe left ventricular dysfunction. The session also addresses...

DCB in diffuse disease and small vessels: LIVE Educational Case from National University Heart Centre - Singapore

10 Oct 2025 – From AICT-AsiaPCR 2025

This educational session focuses on the application of drug-coated balloons (DCB) in the management of diffuse coronary disease and small vessel pathology. It guides clinicians in identifying suitable lesion subsets, optimizing lesion preparation using advanced imaging and physiological assessments, and determining the appropriate timing to transition...

Nightmare in cathlab

10 Oct 2025 – From AICT-AsiaPCR 2025

This session provides comprehensive guidance on managing complications encountered in the catheterization laboratory. It covers practical approaches to a range of procedural complications, strategies to prevent vascular site issues in emergency situations, and essential tips for managing coronary perforations, aneurysms, and complications during vessel preparation. The...

Left main PCI - LIVE Case

10 Oct 2025 – From AICT-AsiaPCR 2025

A 78-year-old male with a history of LAD PCI in 1997 presented with an NSTEMI three months earlier due to diffuse three-vessel calcified disease, including: distal LM stenosis, severe mid and distal disease of a dominant RCA, and LAD in-stent restenosis. LV function was normal. He...

Left main PCI - LIVE Case

EuroPCR 2026 – Coronary revascularisation in patients undergoing TAVI

20 May 2026

Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is an individual participant data meta-analysis of 4 randomised controlled trials...

EuroPCR 2026 – Coronary revascularisation in patients undergoing TAVI

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

23 Jan 2025

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.

Author

Hector Garcia-Garcia
Jorge Sanz Sanchez

Author

Jorge Sanz-Sanchez
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?